SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-011688
Filing Date
2011-03-01
Accepted
2011-02-28 19:48:57
Documents
13
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v212557_10k.htm 10-K 1596548
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
4 v212557_ex10-1.htm EX-10.1 78046
5 v212557_ex10-21.htm EX-10.21 42199
6 GRAPHIC logo.jpg GRAPHIC 21807
7 v212557_ex10-24.htm EX-10.24 188319
8 v212557_ex23-1.htm EX-23.1 3769
9 v212557_ex23-2.htm EX-23.2 3904
10 v212557_ex31-1.htm EX-31.1 17207
11 v212557_ex31-2.htm EX-31.2 17203
12 v212557_ex32-1.htm EX-32.1 7830
13 v212557_ex32-2.htm EX-32.2 8099
  Complete submission text file 0001144204-11-011688.txt   1995236
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33038 | Film No.: 11648460
SIC: 8093 Services-Specialty Outpatient Facilities, NEC